This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 14

Based on the information you provided, we found the following studies.

  • Evaluation of Urine and Blood Biomarkers as Noninvasive Tools for Cancer Monitoring The purpose of this study is to see if we can develop a biomarker (a kind of test) from blood or urine samples to monitor a patient¿s cancer. Currently, the only way of monitoring a patient¿s cancer is by scans (i.e. CT, MRI, PET). This study is researching all of the following topics: Colorectal / Colon / Rectal cancer Lung cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Healthy volunteers
    • More than 21 years old
  • A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients with Locally Advanced Non-Small Cell Lung Cancer Use Fluorodeoxyglucose–Positron Emission Tomography (FDG-PET, a PET scan) + Ventilation/Perfusion Single Photon Emission Computerized Tomography (V/Q SPECT, a perfusion scan), before + during treatment to see if this helps predict how well the treatment works + your lung functions during treatment. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients The purpose of this research study is to evaluate the ability of MK-3475 to control your cancer for a longer period of time following completion of initial chemotherapy. MK-3475 is an investigational drug for your type of cancer. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of Investigational Drug INCB054828 in Subjects with Advanced Malignancies Study goals: determine dose that is safe and tolerable in people with advanced cancer and select the doses that will be studied further; see how INCB054828 acts on and in the body; see effect INCB054828 has on the growth of your cancer; see action of INCB054828 in the body over a period of time This study is researching all of the following topics: Bladder cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Multiple myeloma Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Personalized Adaptive Radiation Therapy with Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer with Genomic Driver Mutations The purpose of this study is to determine if the combination of FDG-PET/CT ¿adapted radiation therapy plus targeted therapy with either erlotinib (Tarceva) or crizotinib (Xalkori) is safe and effective in people with your stage and type of lung cancer. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Pilot Study of investigational drug MPDL3280A (PD-L1 Antibody Therapy and Hypofractionated Image-guided Radiotherapy (HIGRT) in Patients with Metastatic Non-Small Cell Lung Cancer Purpose: see if a brief course of radiation therapy given to one area affected by the cancer will improve chances of responding to immuno-therapy MPDL3280A; see if prior treatment with radiation will allow improved recognition of the cancer by the body¿s immune cells in the presence of MPDL3280A. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of investigational drug INCB054329 (Study Drug) in Subjects With Advanced Malignancies (INCB 54329-101) Study purpose:determine dose that is safe and tolerable and select the doses that will be studied further;understand how INCB054329 enters and leaves the body over time;understand how INCB054329 acts on and in the body;observe any effects INCB054329 may have on the growth of certain types of cancers This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) Breast cancer CLL ( Chronic lymphocytic leukemia) Colon Cancer ( Malignant tumor of colon ) Lung cancer Pancreatic cancer Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Multicenter, Open-label, Dose-Escalation Study of Oral LEE011 in Patients with Advanced Solid Tumor or Lymphomas This study will evaluate the safety of an investigational drug called LEE011 administered to adult patients with advanced malignant solid tumors or lymphomas. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Lymphoma Melanoma Other Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 14 studies
Show more studies